Thermic Science Files 2021 Second Quarter Financials Ending June 30, 2021, Continuing to Bring the Company in Compliance with the OTC Market to Pink Current Status and No Shell Designation by Filing its Financials & Business Activities Reporting Requireme

Author's Avatar
Aug 17, 2021

NASHVILLE, TN / ACCESSWIRE / August 17, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka Endocan Corporation. (WKN:A1W61J) (ISIN:US29271J1097) (OTC:ENDO), is pleased to announce the unaudited interim consolidated financial results of the Company for the second quarter ended June 30, 2021. The full version of the financial statements and the management discussion and analysis can be viewed on: